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homocysteine (Hey), with coronary artery disease in Japanese males. The
diagnosis of coronaty artery disease of all the studied patients were con-
firmed by coronaty angiography. The AW polymorphism was analyzed by
PCR followed by f-finfl digestion. The screening of 778 male volunteer con-
trols revealed that the allele frequency of the substitution in Japanese is
0.33, comparable with that in French Canadian population, which have been
reported. The VVgenotype, which correlates with increased plasma Hcy lev-
els due to the reduced activity and increased thermolability of this anzyme,
is significantly more frequent in patients with myocardial infarction (17.3%,
n = 202) than in controls (10.2Yo,n = 778) (P = 0.0048). In mntrast, the
frequency of the IWgenotype in patients with non-occlusive coronary artery
dieease (11.8%,n= 144)was not significantly higherthan that in controls. The
fasting plasma Hcy levels in VVsubjects were higher than those in AVand
AA subjects. We conclude that the VVgenotype of MTHFR associated with
increased plasma Hcy levels may represent an important genetic risk factor
for coronary artery disease, especially with the occurrenw of myocardial
infarction.
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El7701 CardiacTiaaueAngiotenainConvertingEnzyme(ACE)BindingSitaaareIncraasedin HumanHeati
Failure
L.S. Zisman, D.L. Dutcher, M. Jenkin, E.W. Bush, T. Bohlmeyer,
M.R. Bristow, M.B. Perfymen. Univefsifyof Colorado Health Sciencea
Centec Denvec CO, USA
Previous studies have shown that ACE mRNA abundance is increased in
failing compared to nonfailing human heart. However, it is not known if ACE
density is comespondingly increased in cardiac tissue from failing human
hearls. Furthermore, the cellular bcation of ACE production in the human
heart is not known. We used radioligand binding with 3H-ramiprflatto quantify
the density of ACE in eolubilized left ventricular membranes from failing and
nonfailing explanted human hearts, and in situ PCR to localize ACE mRNA
to specific cell types in human left ventricles (LVS). Binding studiee were
performed on 32 failing hearts obtained at the time of cardiac transplantation
from patients with idiopathic dilated cardiomyopathy (lDC) and 24 nonfailing
hearts. ACE Bmax in LV membranes from the IDC hearts was 548 + 40
fmollmg compared to 346 * 30 fmol/mg for the nonfailing hearts (mean +
SEM, p <0.001, unpaired t-test). /nsitu PCRperformed ontieauefrom2 IDC,
2 iachemic, end 4 nonfailing hearts demonstrated ACE mRNA in endothelial
cells and csrdiac myccytes. There was no difference in localization pettern
in failing veraus non-failing hearta.
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Cone/uaions:1)ACE binding sites are increased in failing human heart; 2)
ACE mRNA is localized to endothelial cells and cardiac myocytes in human
heart.
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El7702 Long-TermACEInhibitionAttenueteeCardiocyteApoptoaieinDogsWithModerateHeartFailure
A. Goussev, H.N. Sabbah, V.G. Sharov, H. Shimoyama, M. Lesch,
S. Goldstein. Henry Ford Hear?and Vascular lrrstitute, Detroit, Ml, USA
We previously showed that cardiocyfe apoptosis (programmed cell death)
occurs in dogs with chronic heart failure (HF). We also showed that early,
long-term therapy with the ACE inhibitor enalapril (ENA) attenuates the pro-
gressive loss ofcerdiocyfes in myocardium of HF dogs and presewes overall
LV function. In the present study, reexamined the possibility that the attenu-
ation of the progressive loss of cardiocytea in dogs with HF treated with ENA
may be due, in part, to attenuation of cardiocyte apoptosis. A total of 14 HF
dogs (EF 30%-40%), produced by intracoronary microembolizations, were
randomized to 3 months therapy with ENA (10 mg Bid, n = 7)’orto no therapy
at all (CONTROL, n = 7). At the end of 3 months of therapy, dogs were sac-
rificed and the hearts removed. The presence of nuclear DNA fragmentation
(DNAf), a marker of apoptosis, was assessed in frozen LVsections using the
Oncor ApepTagfluorescein kit. Sections were double stained with ventricular
antimyosin antibody to identify cells of cardiccyfe origin. A total of 20 fields
(magnification x40) were examined from sections obtained from each dog.
Among cells of cerdiocyte origin, the number of nuclear DNAf eventa was
significantly lower in Entreated dogs compared to CONTROL (0.084Z0.06
vs. 0.39 + 0.12 DNAf eventa/fieid) (p= 0.039). Conclusions: Early, long-term
therapy with ENA attenuates cardiocyte apoptosis in dogs with mcderate
HF.Attenuation of cardiocyte death by apoptosis may be one mechanism by
which ENA attenuates the ongoing loss of viable cardiocytes and presewes
overall LV function of the failing LV.
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m7703 NorapinephrineDirectlyInduceaApoptoaiainNeonatalRatMyocytea
T. Matsui, R.J, Hajjar, J.X. Kang, A. Rosenzweig. Cardiovascular Research
Centec Massechusei?s,USA, General Hospital, Chsrfestown, MA, USA
Congestive heart failure (CHF) is accompanied by elevated levels of cete-
cholamines which are known to produce cardiac toxicity but the underlying
mechanism has not been elucidated. Apoptosis has been documented re-
cently in animal models of heart failure and in patients with dilated cardiomy-
opathy. To test the hypothesis that catecholamines directly induce cardiocyte
S@OPtOSiS, We exposed nSOnatSlrat myocytes to norepinephrine (NE) (0.1
KM, 1 #M, or 10 KM for96 hra). We evaluated cultured cells forapoptoais by
1) nucleosome Iaddering (DNA electrophoresis), 2) Hoechst staining for nu-
clear morphology, 3) terminal deoxynucleotidyl transferase mediated dUTP
nick end labeling (TUNEL), 4) Flow cytometry (FACS), and 5) Poly ADP-
Ribese Polymeraee (PARP) fragmentation (Western blotting). Results of all
aaaays were consistent with FACS which provided the most precise quan-
titation of apoptoais. Although basal cardiocyte culturea exhibit a low level
of apoptosis (0.42% by FACS), NE stimulation induced significantly greater
apeptosis in a dose-dependent manner (33.97% at 10 KM by FACS). TUNEL
assay and DNA electrophoresis were diagnostic of apoptotic cell death after
NE treatment. Western blotting, using the anti-PARP monoclinal antibody
demonstrated PARP cleavage consistent with ICE-family proteases. Addi-
tion of prezosin (1 wM) or propranolol (1 wM) to NE-stimulated cardiocyle
cultures partially reducad the degree of apoptosis (19.44% at 0.1 KM NE
to 10.33% with prezosin or 14.86% with propranolol). We conclude that (1)
NE directly induces apoptosis in cultured cerdiocytes; (2) this effect is in-
completely blocked by a- or &antagonists; and (3) PARP is cleaved in these
cultures, suggesting ICE-family activation. These findings point to apopto-
sis as a mechanism of adrenergic-mediated myocardial injury and may be
relevant to in vivo hyperadrenergic statas such as CHF.
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[770-4]MicrotubuleAaaemb,YAfiecta@-adrener9ic
MediatedContractilityin HumanIechemicDilated
Cardiomyopathy
R.D. Bies, M. Maeda, E. Holder, S. Valent, R. Roden, W. Abraham,
M. Bristow. Division of Cardio/og~ VAMedical Center and University of
Colorado Health Sciences CenteL Denvec CO, USA
Microtubules (MT) are believed to have a role in modulating contractility and
G protein coupling to adenylyl cyclase in animal models of cardiac myocyte
function. We therefore analyzed the integrity and physiological significance of
microtubule asaembly/disaaaembly in human cardiac tissues. MT separation
from the soluble free tubulin cell fraction was performed on four freshly ex-
planted non-failing human hearts intended fortransplantation, and ten freshly
explanted failing hearts from subjects with ischemic dilated cardiomyopathy
(Isch). Scanning densitometry of Western blots showed a loss of MT in Isch
heatta and a - 65% increase in the ratio of free tubulin verses MT tubulin
(free/MT = 1.14) compared to normal controls (free/MT= 0.69). In tissue bath
experiment, 100 fresh RV trabeculae from 9 Iach hearta were exposed to a
4 hour incubation with 10 KM taxol (TAX) or 10 PM colchicine (COL) to either
increase or disrupt microtubules, respectively,and were compared to vehicle
controls (CON). Isoproterenol (10-9M to 10-4M) stimulated maximal tension
response (mg; stimulated minus basal) was measured and exhibited a 30Y0
increase in peak systolic tension with TAX (1620 mg) compared to CON
(1368 mg) or COL (1455 mg), (p= 0.02). Tension response to direct stimu-
lation with Ca2+ (5 mM and 10 mM) revealed no difference between groupa
(p= 0.7); CON (1401 mg), TAX (1491 mg), COL (1427 mg). These results
